News

PATENTS

Patents Issued:

Patent Number Issue Date Issued To Title
US 7,115,556 03 OCT 2006 Oncolix Use of Anti-Prolactin Agents to Treat Proliferative Conditions
1079851
Europe; Canada
04 JUL 2007 Oncolix Use of Anti-Prolactin Agents to Treat Proliferative Conditions
US 7,201,905 10 APR 2007 Oncolix Bi-Functional Cancer Treatment Agents
US 7,339,027 4 MAR 2008 Oncolix Human Prolactin Antagonist-Angiogenesis Inhibitor Fusion Proteins
US 7,632,809 15 DEC 2009 Oncolix Multimeric Ligands with Enhanced Stability

Patent Applications Filed and Pending:

Patent Number Date Filed Filed By Title
US 11/073,927 8 MAR 2005 Oncolix Use of Prolactin Receptor Antagonists in Combination with an Agent that Inactivates the HER2/neu Signaling Pathway
US 61/155624 26 FEB 2009 Oncolix Compositions and Methods for Visualizing and Eliminating Cancer Stem Cells

14405 Walters Road, Suite 780, Houston, Texas 77014   
info@oncolixbio.com  
©2011-2013 Oncolix, Inc. All Rights Reserved.